Judge Tosses Out $417M Talcum Trial Jury AwardThe judge on Friday granted the company a new trial, saying there were errors in the previous case that ended with the award two months ago.
Los Angeles Jury Orders Johnson & Johnson To Pay $417M To Woman Who Blames Talc Powder For Her CancerEva Echeverria, 63, of Los Angeles, claimed the company failed to warn consumers about cancer risks.
Man Sues Johnson & Johnson For His Wife's Death After Suffering CancerThe plaintiff says his wife died of ovarian cancer after years of using talcum products marketed by the company.
Jury Awards Mother $5.6 Million After Son's Death In Clinical Drug TrialLeo Liu hoped that enrolling in a clinical trial for an anti-psychotic drug in 2009 would help his schizophrenia.
OC DA Charges Pharmaceutical Companies For 'Knowingly Harming Public Health'The makers of OxyContin, as well as other prescription drugs that are considered potentially dangerous and addictive, are the targets of Orange County District Attorney Anthony Rackauckas, who alleged they duped doctors into believing the benefits of time-released, semi-synthetic opioids outweighed the risks.
J&J Recalls Infant Motrin Due To Plastic Specks Johnson & Johnson is recalling 200,000 bottles of Motrin Infants formula due to the risk that they contain tiny plastic particles.
Jury Awards $8.3M To Former Prison Guard In Hip Implant CaseA jury Friday awarded $8.3 million to a former prison guard who accused Johnson & Johnson's DePuy Orthopaedics subsidiary of knowingly marketing a faulty hip implant that was later recalled.
Westchester Man Awarded $48M In Motrin Blood Blister CaseA Southern California jury has awarded $48 million to a man who got a severe skin disorder and mouth blood blisters after taking the pain reliever Motrin.
Stock Market Posts Gains After Mixed Earnings Johnson & Johnson led the Dow Jones industrial average higher on Tuesday. The health-care heavyweight rose 3 percent after reporting earnings that beat Wall Street's expectations. The company also raised its full-year earnings forecast.
Johnson & Johnson Recalls Several Rolaids Products Johnson & Johnson is recalling several types of Rolaids antacids in the U.S. because of reports of metal and wood particles in the products
Johnson & Johnson Issues Tylenol RecallJohnson and Johnson has issued another recall involving Tylenol pills after consumers complained about a musty and moldy odor.